160 related articles for article (PubMed ID: 3137275)
1. Interferon-gamma and antibiotics fail to act synergistically to kill Legionella pneumophila in human monocytes.
Bhardwaj N; Horwitz MA
J Interferon Res; 1988 Jun; 8(3):283-93. PubMed ID: 3137275
[TBL] [Abstract][Full Text] [Related]
2. Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin.
Horwitz MA; Silverstein SC
J Clin Invest; 1983 Jan; 71(1):15-26. PubMed ID: 6848556
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma-activated human monocytes inhibit the intracellular multiplication of Legionella pneumophila.
Bhardwaj N; Nash TW; Horwitz MA
J Immunol; 1986 Oct; 137(8):2662-9. PubMed ID: 3093580
[TBL] [Abstract][Full Text] [Related]
4. Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone.
Nash TW; Libby DM; Horwitz MA
J Clin Invest; 1984 Sep; 74(3):771-82. PubMed ID: 6470140
[TBL] [Abstract][Full Text] [Related]
5. IL-10 enhances the growth of Legionella pneumophila in human mononuclear phagocytes and reverses the protective effect of IFN-gamma: differential responses of blood monocytes and alveolar macrophages.
Park DR; Skerrett SJ
J Immunol; 1996 Sep; 157(6):2528-38. PubMed ID: 8805654
[TBL] [Abstract][Full Text] [Related]
6. IFN-gamma-activated human alveolar macrophages inhibit the intracellular multiplication of Legionella pneumophila.
Nash TW; Libby DM; Horwitz MA
J Immunol; 1988 Jun; 140(11):3978-81. PubMed ID: 3131422
[TBL] [Abstract][Full Text] [Related]
7. Intracellular multiplication of Legionella pneumophila in HL-60 cells differentiated by 1,25-dihydroxyvitamin D3 and the effect of interferon gamma.
Watanabe M; Shimamoto Y; Yoshida S; Suga K; Mizuguchi Y; Kohashi O; Yamaguchi M
J Leukoc Biol; 1993 Jul; 54(1):40-6. PubMed ID: 8336078
[TBL] [Abstract][Full Text] [Related]
8. Formation of a novel phagosome by the Legionnaires' disease bacterium (Legionella pneumophila) in human monocytes.
Horwitz MA
J Exp Med; 1983 Oct; 158(4):1319-31. PubMed ID: 6619736
[TBL] [Abstract][Full Text] [Related]
9. Activated human monocytes inhibit the intracellular multiplication of Legionnaires' disease bacteria.
Horwitz MA; Silverstein SC
J Exp Med; 1981 Nov; 154(5):1618-35. PubMed ID: 7299350
[TBL] [Abstract][Full Text] [Related]
10. Interferon gamma-activated human monocytes downregulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron.
Byrd TF; Horwitz MA
J Clin Invest; 1989 May; 83(5):1457-65. PubMed ID: 2496141
[TBL] [Abstract][Full Text] [Related]
11. Lactoferrin inhibits or promotes Legionella pneumophila intracellular multiplication in nonactivated and interferon gamma-activated human monocytes depending upon its degree of iron saturation. Iron-lactoferrin and nonphysiologic iron chelates reverse monocyte activation against Legionella pneumophila.
Byrd TF; Horwitz MA
J Clin Invest; 1991 Oct; 88(4):1103-12. PubMed ID: 1918366
[TBL] [Abstract][Full Text] [Related]
12. [Immunopathogenesis of Legionnaires' disease].
Alim A
Mikrobiyol Bul; 2004 Jul; 38(3):295-303. PubMed ID: 15490851
[TBL] [Abstract][Full Text] [Related]
13. Involvement of tumor necrosis factor alpha in intracellular multiplication of Legionella pneumophila in human monocytes.
Matsiota-Bernard P; Léfèbre C; Sedqui M; Cornillet P; Guenounou M
Infect Immun; 1993 Dec; 61(12):4980-3. PubMed ID: 8225572
[TBL] [Abstract][Full Text] [Related]
14. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
Stout JE; Arnold B; Yu VL
Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila.
Baltch AL; Smith RP; Ritz W
Antimicrob Agents Chemother; 1995 Aug; 39(8):1661-6. PubMed ID: 7486896
[TBL] [Abstract][Full Text] [Related]
16. Speculations on the influence of infecting phenotype on virulence and antibiotic susceptibility of Legionella pneumophila.
Barker J; Brown MR
J Antimicrob Chemother; 1995 Jul; 36(1):7-21. PubMed ID: 8537286
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.
Edelstein PH; Edelstein MA
Antimicrob Agents Chemother; 1999 Jan; 43(1):90-5. PubMed ID: 9869571
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial effect of telithromycin (HMR 3647) and comparative antibiotics against intracellular Legionella pneumophila.
Baltch AL; Smith RP; Ritz WJ; Franke MA; Michelsen PB
J Antimicrob Chemother; 2000 Jul; 46(1):51-5. PubMed ID: 10882688
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. II. Antibody promotes binding of L. pneumophila to monocytes but does not inhibit intracellular multiplication.
Horwitz MA; Silverstein SC
J Exp Med; 1981 Feb; 153(2):398-406. PubMed ID: 7241049
[TBL] [Abstract][Full Text] [Related]
20. Efficient intracellular multiplication of Legionella pneumophila in human monocytes requires functional host cell L-type calcium channels.
Wieland H; Hechtel N; Faigle M; Neumeister B
FEMS Immunol Med Microbiol; 2006 Jul; 47(2):296-301. PubMed ID: 16831218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
